Millian Craig Stuart 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Feb 4, 2021
Insider Transaction Report
Form 4
Millian Craig Stuart
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-02+307,300→ 307,300 totalExercise: $2.58Exp: 2031-02-02→ Common Stock (307,300 underlying) - Award
Stock Option (right to buy)
2021-02-02+307,300→ 307,300 totalExercise: $2.58Exp: 2031-02-02→ Common Stock (307,300 underlying)
Footnotes (2)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022.
- [F2]Represents a special retention award comprised of options to purchase common stock. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022